Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Smoking Cessation 1Neoplasms 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 3Nivolumab 3Magnetic Resonance Spectroscopy 3Radiotherapy 2Ipilimumab 2Fluorodeoxyglucose F18 2Cyclophosphamide 2sugemalimab 1semaglutide 1sacituzumab govitecan 1prednylidene 1pirtobrutinib 1paricalcitol 1mirdametinib 1gadobutrol 1fludarabine phosphate 1fludarabine 1erdafitinib 1enfortumab vedotin 1deltacortene 1daratumumab 1brivaracetam 1brexucabtagene autoleucel 1azeliragon 1avelumab 1alovudine 1acalabrutinib 1Watchful Waiting 1Vorinostat 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Acceptance and Commitment Therapy × 30 days × Clear all
NCT01098955 2026-05-22

Smoking Cessation Treatment for Head & Neck Cancer Patients

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
51 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡